IPSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.9 EUR | +0.25% |
|
+4.72% | +11.12% |
| May. 02 | Ipsen Announces Executive Changes | CI |
| May. 02 | Ipsen: new President for North America | CF |
ETFs positioned on Ipsen
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.83% | 0 M€ | +10.59% | ||
| 0.43% | 0 M€ | +8.19% | ||
| 0.31% | 3 M€ | +9.95% | - | |
| 0.24% | 0 M€ | +3.57% | ||
| 0.24% | 5 M€ | +4.56% | ||
| 0.16% | 5 M€ | +10.09% | - | |
| 0.16% | 14 M€ | +5.66% | - | |
| 0.10% | 2 M€ | -.--% | - | |
| 0.10% | 2 M€ | +9.19% | - | |
| 0.09% | 0 M€ | +6.60% | - | |
| 0.05% | 6 M€ | -.--% | - | |
| 0.04% | 6 M€ | -.--% | ||
| 0.03% | 0 M€ | +7.24% | - | |
| 0.03% | 10 M€ | -3.35% | - | |
| 0.02% | 7 M€ | +0.11% | - | |
| 0.02% | 23 M€ | -.--% | - | |
| 0.02% | 786 M€ | -.--% | ||
| 0.01% | 206 M€ | -.--% | ||
| 0.01% | 607 M€ | +0.05% | ||
| 0.01% | 1,166 M€ | +0.26% | ||
| 0.01% | 0 M€ | +18.97% | ||
| 0.00% | 284 M€ | -.--% | ||
| 0.00% | 0 M€ | +8.70% | - | |
| 0.00% | 0 M€ | +8.24% | - | |
| 0.00% | 0 M€ | +3.63% | - |
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
Pharmaceuticals
Calendar
2024-05-28
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
119.9
EUR
Average target price
125.5
EUR
Spread / Average Target
+4.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.12% | 10.67B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- IPN Stock
- Funds and ETFs Ipsen